Engineered T cells and macrophages: two arms to seize solid tumors
Current Opinion in Biotechnology · 2025-06 · 93 · 103296
DOI: 10.1016/j.copbio.2025.103296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2025-06. Verfasst von Luigi Russo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Italiano di Tecnologia - IIT, Largo Barsanti e Matteucci 53, Naples, Italy. Electronic address: luigi.russo2@iit.it. Hauptthemen laut MEDLINE: Neoplasms, T-Lymphocytes, Macrophages, Immunotherapy, Adoptive. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Airc Italian Foundation for Cancer Research, HORIZON EUROPE European Research Council, European Research Council.
Abstract (Originalsprache)
Following the breakthroughs of CAR T cells in the treatment of several hematological malignancies, clinical trials based on genetically modified immune cells are exponentially increasing. Redirecting T cell cytotoxicity against solid tumors via CARs, however, encountered several barriers that require the engineering of additional functions to improve safety, migration, efficacy, and persistence in solid tumors. Complementary strategies tried to harness macrophage properties such as cancer cell phagocytosis, cytokine release, and antigen presentation to induce broader antitumorigenic immune response. While providing a comprehensive overview on the latest technologies in the cell-based immunotherapy realm, we propose that engineering synthetic interplay between immune cells will be the next breakthrough to drive safer and more effective living therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Istituto Italiano di Tecnologia - IIT, Largo Barsanti e Matteucci 53, Naples, Italy. Electronic address: luigi.russo2@iit.it.
- Istituto Italiano di Tecnologia - IIT, Largo Barsanti e Matteucci 53, Naples, Italy.
- Istituto Italiano di Tecnologia - IIT, Largo Barsanti e Matteucci 53, Naples, Italy. Electronic address: velia.siciliano@iit.it.
Förderung
- Airc Italian Foundation for Cancer Research
- HORIZON EUROPE European Research Council
- European Research Council
- European Molecular Biology Organization
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Russo, L., De Martino, I., Marchetti, M., & Siciliano, V. (2025). Engineered T cells and macrophages: two arms to seize solid tumors. Current Opinion in Biotechnology, 93, 103296. https://doi.org/10.1016/j.copbio.2025.103296
Vancouver
Russo L, De Martino I, Marchetti M, Siciliano V. Engineered T cells and macrophages: two arms to seize solid tumors. Current Opinion in Biotechnology. 2025;93:103296. doi:10.1016/j.copbio.2025.103296
BibTeX
@article{Russo2025,
author = {Russo, Luigi and De Martino, Ilaria and Marchetti, Matteo and Siciliano, Velia},
title = {Engineered T cells and macrophages: two arms to seize solid tumors},
journal = {Current Opinion in Biotechnology},
year = {2025},
volume = {93},
pages = {103296},
doi = {10.1016/j.copbio.2025.103296}
}
EUVIMED